Fondaparinux
（重定向自Arixtra）
![](/Images/godic/202412/21/Fondaparinux.svg5023.png")
Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.